- Corona-Risk factors: Researchers discover new ones Biomarker
- Protein should severe illness guess
- The decisive factor is: Protein concentration
- Analyzes can be Immunotherapy activation
Some people infected with coronavirus barely notice anything. Others become seriously ill and must be hospitalized. about Risk factors Even today – a year after the global pandemic of the Covid 19 pandemic – there is still no clear cut. Erlangen researchers now there is a reference to one Biomarker discovered, of Predict severe disease progression and maybe even activate treatment.
One thing is for sure so far: older people have a higher chance of getting seriously ill with Covid-19. Other factors such as smoking increase the risk of serious illness. Obesity can also promote serious progression.
However, there is still no agreement on the mechanisms that increase the risk of serious corona disease. And again and again, people who don’t actually belong to any risk group get seriously ill.
Coronary disease course: protein concentration should provide an estimate
Two physicians from Erlangen – Dr. Georg Weber, deputy clinical director and senior physician at the Erlangen University Clinic surgical clinic, and Dr. Alan Bnard, who works in the surgical clinic, now gives hope for better identification of the severe disease. Even therapy is possible.
Book tip: Prof.Dr. Dr. Alexander Kekul – Corona Compass
Together with other researchers from the “Inflammation and cellular immunity in cancer” working group at the University Hospital of Erlangen, the two have a major problem. Frhindikator To discover whether the viral infection will be mild or severe: Immunbotenstoff Interleukin-3. The results of the study were published in the journal “Nature Communications”.
Interleukin-3 a Proteinwhich stimulates people’s natural immune defense. It stimulates the blood formation process and is therefore used to promote blood formation, for example after bone marrow transplant, general anemia or after chemotherapy.
Immunotherapy: New treatment method may protect lungs from coronavirus invasion
Weber and Bnard now in a study low levels of interleukin-3 often in blood plasma severe course of Covid-19 disease goes hand in hand. Interleukin-3 plays an important role in regulating the body’s immune response. At an inflammation site – for example pneumonia caused by SARS-Cov-2 – stimulates cells there to produce the CXCL12 protein.